People

Theranos by the numbers: Do forecasts show fraud or failure?

Prosecutors and defense attorneys argued over what Theranos' lofty revenue projections meant as the Elizabeth Holmes trial continued in San Jose.

Elizabeth Holmes and her mother leave the courthouse in San Jose.

Elizabeth Holmes and her mother leave the courthouse in San Jose on Tuesday, Sept. 14, 2021.

Photo: Biz Carson/Protocol

Theranos inflated its revenue projections when, behind the scenes, insiders knew the startup had widening losses and dwindling revenue, prosecutors argued on the second day of the Elizabeth Holmes trial.

The testimony was the first glance under the hood of Theranos, a blood-testing company which once promised to revolutionize the detection of disease. Holmes, its former CEO, is standing trial for wire fraud and conspiracy to commit wire fraud in San Jose.

One of the prosecution's key arguments is that Theranos wildly inflated its revenue projections to attract investors. As its first witness, the government called former Theranos controller So Han Spivey, who also goes by Danise Yam, and walked through spreadsheet after spreadsheet of the company's historic financials.

Her testimony painted a picture of a company that saw its cash dwindling as revenues shrank, with a few particularly tense moments in 2009 and 2013 as it burned millions of dollars a week. But the company buoyed its balance sheet by attracting around $945 million from investors — investors whom, the government contends, Holmes misled as she pitched them.

The loftiest revenue projections appeared in a mysterious document that Spivey said she had no hand in preparing. Without offering the jury specifics on the document's origins, prosecutors suggested the financial forecasts were something investors had seen. The document showed Theranos expected to generate $140 million in revenue in 2014 and $990 million in 2015.

"Do you have any idea where that number came from?" Assistant U.S. Attorney Robert Leach asked Spivey. "No," she replied.

The forecast of nearly a billion dollars in revenue was higher than what Holmes presented to an outside firm which prepared a 409A valuation, an assessment of the fair-market value of the company's stock for compensation purposes. The numbers Spivey said she received from Holmes had previously forecasted $50 million in 2013, $90 million in 2014 and $112 million in 2015. In another email, Holmes confirmed forecasts of $100 million in revenue in 2015, rising to $500 million in subsequent years.

Defense attorneys for Elizabeth Holmes leave the courthouse in San Jose on Tuesday, Sept. 14, 2021.Photo: Biz Carson/Protocol

Defense attorneys countered that much of the discrepancy came from Theranos' deferred revenue.

Theranos' actual revenue had fallen from $1.4 million in 2010 to $518,000 in 2011 and down to zero in 2012 and 2013. At the time, its losses also grew from $16.2 million in 2010 to nearly $57 million by 2012. By 2013, Theranos was burning roughly $2 million a week, Spivey said.

Holmes' lawyers argued that the losses were normal for a Silicon Valley startup who was spending heavily on R&D and had signed plenty of revenue-generating contracts with companies like Merck and Pfizer.

The prosecution, meanwhile, pressed Spivey on the company's spending, attempting to paint a portrait of corporate excess, but didn't extract many details from the former controller.

Spivey couldn't recall how much Theranos had spent on private jets, but confirmed that Holmes did fly private. She also said that Holmes had been paid $200,000 a year from 2010 to 2014 before her salary increased to $400,000 in 2015.

A more insightful witness into the company's culture will be whistleblower Erika Cheung, who worked in Theranos' clinical and R&D labs. She began her testimony Tuesday describing how she wanted to work for a charismatic Holmes but found a secretive work environment where employees were told to keep Theranos off their LinkedIn profiles.

See Protocol's in-depth coverage of the Theranos trial for more.

Protocol | Fintech

Crypto has a payment for order flow problem, too

The SEC is concerned about payment for order flow in stocks and options. But crypto, which it is struggling to regulate, is a "Wild West."

What are you paying for your bitcoin?

Illustration: Jeremy Bezanger / Unsplash

Two of the SEC's major concerns are payment for order flow, the potentially conflict-ridden system where retail brokers get paid by market makers for sending them orders, and cryptocurrencies, the largely unregulated digital tokens that are generating a booming market in speculative trading.

What if you put them together?

Keep Reading Show less
Tomio Geron

Tomio Geron ( @tomiogeron) is a San Francisco-based reporter covering fintech. He was previously a reporter and editor at The Wall Street Journal, covering venture capital and startups. Before that, he worked as a staff writer at Forbes, covering social media and venture capital, and also edited the Midas List of top tech investors. He has also worked at newspapers covering crime, courts, health and other topics. He can be reached at tgeron@protocol.com or tgeron@protonmail.com.

While it's easy to get lost in the operational and technical side of a transaction, it's important to remember the third component of a payment. That is, the human behind the screen.

Over the last two years, many retailers have seen the benefit of investing in new, flexible payments. Ones that reflect the changing lifestyles of younger spenders, who are increasingly holding onto their cash — despite reports to the contrary. This means it's more important than ever for merchants to take note of the latest payment innovations so they can tap into the savings of the COVID-19 generation.

Keep Reading Show less
Antoine Nougue,Checkout.com

Antoine Nougue is Head of Europe at Checkout.com. He works with ambitious enterprise businesses to help them scale and grow their operations through payment processing services. He is responsible for leading the European sales, customer success, engineering & implementation teams and is based out of London, U.K.

People

Theranos machines often failed tests, ex-employee testifies

The testimony from lab-worker-turned-whistleblower Erika Cheung could form a crucial piece of government prosecutors' fraud case against former Theranos CEO Elizabeth Holmes.

The former Theranos headquarters in Palo Alto.

Photo: Andrej Sokolow via Getty Images

Did Theranos' blood-testing technology work? That was the key question prosecutors hammered away at as the fraud trial of former CEO Elizabeth Holmes continued Wednesday in a San Jose courtroom.

The company's proprietary Edison machines routinely failed quality control tests to the point that former lab employee Erika Cheung said she sometimes refused to run patient samples on the devices, she testified in court.

Keep Reading Show less
Biz Carson

Biz Carson ( @bizcarson) is a San Francisco-based reporter at Protocol, covering Silicon Valley with a focus on startups and venture capital. Previously, she reported for Forbes and was co-editor of Forbes Next Billion-Dollar Startups list. Before that, she worked for Business Insider, Gigaom, and Wired and started her career as a newspaper designer for Gannett.

Protocol | Policy

Big Tech builds bit by bit. The FTC is challenging that.

The FTC on Wednesday unveiled the findings of a study on the small deals that helped Big Tech grow without regulatory scrutiny, and took steps to treat such acquisitions more skeptically.

The FTC is putting more scrutiny on the small deals that built Big Tech.

Photo: Ian Hutchinson/Unsplash

The Federal Trade Commission on Wednesday took a dive into the kinds of deals that make Big Tech, well, big.

The commission unveiled findings from an investigation into hundreds of small acquisitions that companies such as Facebook, Amazon and Google undertook with little government oversight, which helped those titanic businesses reach their current size and power. Some of those transactions evaded regulator scrutiny thanks to loopholes in the law, the report found.

Keep Reading Show less
Ben Brody

Ben Brody (@ BenBrodyDC) is a senior reporter at Protocol focusing on how Congress, courts and agencies affect the online world we live in. He formerly covered tech policy and lobbying (including antitrust, Section 230 and privacy) at Bloomberg News, where he previously reported on the influence industry, government ethics and the 2016 presidential election. Before that, Ben covered business news at CNNMoney and AdAge, and all manner of stories in and around New York. He still loves appearing on the New York news radio he grew up with.

Protocol | China

Tencent dominates digital donations in China. That’s the problem.

After building the only successful digital fundraising platform in China, Tencent's immense impact in the charity world raises questions about inequality, state censorship and platform responsibility.

Tencent's 99 Giving Day has grown into a behemoth, facilitating million of dollars' worth of donations on a yearly basis.

Image: Christopher T. Fong / Protocol

An hour before September 9, Eric, a nonprofit fundraising worker in southern China, was as frustrated as he'd been in months. It was way past his normal work hours, but he had just finished writing a few paragraphs he hoped to send to people tomorrow to ask for donations. He received his first blow from one friend, who commented that his plan felt "insincere;" and then, during a WeChat conversation with another friend, he casually brought up the project he was fundraising for and got the half-joking reply: "Don't do this to me." Eric's frustration was verging on anger.

For Eric, and countless nonprofit workers in China, this wasn't a normal day. Tomorrow would be the "99 Giving Day," an online donation bonanza that Tencent, one of China's most prominent tech companies, created in 2015 and has since grown into the most important event annually for charity workers. Every year for a few days leading up to Sept. 9, Tencent takes out tens of millions of dollars' worth of its own money to match the donations made on its Tencent Charity platform, a mini-app in WeChat where thousands of fundraising projects are listed. But to make the magic happen on these few days, nonprofit workers often start preparing months in advance, learning the platform's arcane rules, planning their strategies and mobilizing their giving communities. As the event grows bigger and the rules grow more complicated, the work is taking an emotional toll on people like Eric.

Keep Reading Show less
Zeyi Yang
Zeyi Yang is a reporter with Protocol | China. Previously, he worked as a reporting fellow for the digital magazine Rest of World, covering the intersection of technology and culture in China and neighboring countries. He has also contributed to the South China Morning Post, Nikkei Asia, Columbia Journalism Review, among other publications. In his spare time, Zeyi co-founded a Mandarin podcast that tells LGBTQ stories in China. He has been playing Pokemon for 14 years and has a weird favorite pick.
Latest Stories